Table 1.

2019 CERA Program Director Survey Questions: Pharmaceutical Industry Interaction in US Family Medicine Residencies

Survey QuestionResponse Options
Does your residency allow gifts from industry or industry-supported food?

  • ▪ Yes

  • ▪ No

Are drug samples accepted at the residency?

  • ▪ Yes

  • ▪ No

Are industry representatives allowed access to medical students and/or residents at the family medicine center? (Note: This does not include access required for device training, such as Nexplanon)*

  • ▪ Yes

  • ▪ No

Are any industry-sponsored residency activities allowed?

  • ▪ Yes

  • ▪ No

Does your residency have a formal curriculum that explores the interactions between physicians and the pharmaceutical industry?

  • ▪ Yes

  • ▪ No

In the past five years how has your program’s interaction with the pharmaceutical industry changed? (through samples, visits from representatives, gifts/food, and sponsored activities):

  • ▪ Increased

  • ▪ Decreased

  • ▪ Stayed the same

  • ▪ Don’t know

 If decrease: What were the major factors that led to a decrease in pharmaceutical interaction? (Pick all that apply)

  • ▪ Local response to national legislation (2013 Sunshine Act requiring documentation of all gifts)

  • ▪ Ethical concerns

  • ▪ Resident input

  • ▪ Faculty input

  • ▪ Institutional policy

  • ▪ Other

 If increase: What were the major factors that led to an increase in pharmaceutical interaction? (Pick all that apply)

  • ▪ Resident input

  • ▪ Faculty input

  • ▪ Need for samples

  • ▪ Resources (e.g. food for lunches)

  • ▪ Institutional policy

  • ▪ Educational factors (e.g., exposure to teach interaction)

  • ▪ Other

  • ↵* The device clarification was added in the 2019 survey based on some feedback from pre-survey peer review and our 2013 study.